Designing comparative effectiveness trials of surgical ablation for atrial fibrillation

Experience of the Cardiothoracic Surgical Trials Network

A. Marc Gillinov, Michael Argenziano, Eugene H. Blackstone, Alexander Iribarne, Joseph J. Derose, Gorav Ailawadi, Mark J. Russo, Deborah D. Ascheim, Michael K. Parides, Evelio Rodriguez, Denis Bouchard, Wendy C. Taddei-Peters, Nancy L. Geller, Michael A. Acker, Annetine C. Gelijns

    Research output: Contribution to journalArticle

    17 Citations (Scopus)

    Abstract

    Objective: Since the introduction of the cut-and-sew Cox maze procedure for atrial fibrillation, there has been substantial innovation in techniques for ablation. Use of alternative energy sources for ablation simplified the procedure and has resulted in dramatic increase in the number of patients with atrial fibrillation treated by surgical ablation. Despite its increasingly widespread adoption, there is lack of rigorous clinical evidence to establish this procedure as an effective clinical therapy. Methods: This article describes a comparative effectiveness randomized trial, supported by the Cardiothoracic Surgical Clinical Trials Network, of surgical ablation with left atrial appendage closure versus left atrial appendage closure alone in patients with persistent and long-standing persistent atrial fibrillation undergoing mitral valve surgery. Nested within this trial is a further randomized comparison of 2 different lesions sets: pulmonary vein isolation and the full maze lesion set. Results: This article addresses trial design challenges, including how best to characterize the target population, operationalize freedom from atrial fibrillation as a primary end point, account for the impact of antiarrhythmic drugs, and measure and analyze secondary end points, such as postoperative atrial fibrillation load. Conclusions: This article concludes by discussing how insights that emerge from this trial may affect surgical practice and guide future research in this area.

    Original languageEnglish (US)
    JournalJournal of Thoracic and Cardiovascular Surgery
    Volume142
    Issue number2
    DOIs
    StatePublished - Jan 1 2011

    Fingerprint

    Atrial Fibrillation
    Atrial Appendage
    Ablation Techniques
    Pulmonary Veins
    Health Services Needs and Demand
    Anti-Arrhythmia Agents
    Mitral Valve
    Clinical Trials
    Therapeutics

    All Science Journal Classification (ASJC) codes

    • Surgery
    • Pulmonary and Respiratory Medicine
    • Cardiology and Cardiovascular Medicine

    Cite this

    Designing comparative effectiveness trials of surgical ablation for atrial fibrillation : Experience of the Cardiothoracic Surgical Trials Network. / Gillinov, A. Marc; Argenziano, Michael; Blackstone, Eugene H.; Iribarne, Alexander; Derose, Joseph J.; Ailawadi, Gorav; Russo, Mark J.; Ascheim, Deborah D.; Parides, Michael K.; Rodriguez, Evelio; Bouchard, Denis; Taddei-Peters, Wendy C.; Geller, Nancy L.; Acker, Michael A.; Gelijns, Annetine C.

    In: Journal of Thoracic and Cardiovascular Surgery, Vol. 142, No. 2, 01.01.2011.

    Research output: Contribution to journalArticle

    Gillinov, AM, Argenziano, M, Blackstone, EH, Iribarne, A, Derose, JJ, Ailawadi, G, Russo, MJ, Ascheim, DD, Parides, MK, Rodriguez, E, Bouchard, D, Taddei-Peters, WC, Geller, NL, Acker, MA & Gelijns, AC 2011, 'Designing comparative effectiveness trials of surgical ablation for atrial fibrillation: Experience of the Cardiothoracic Surgical Trials Network', Journal of Thoracic and Cardiovascular Surgery, vol. 142, no. 2. https://doi.org/10.1016/j.jtcvs.2011.04.010
    Gillinov, A. Marc ; Argenziano, Michael ; Blackstone, Eugene H. ; Iribarne, Alexander ; Derose, Joseph J. ; Ailawadi, Gorav ; Russo, Mark J. ; Ascheim, Deborah D. ; Parides, Michael K. ; Rodriguez, Evelio ; Bouchard, Denis ; Taddei-Peters, Wendy C. ; Geller, Nancy L. ; Acker, Michael A. ; Gelijns, Annetine C. / Designing comparative effectiveness trials of surgical ablation for atrial fibrillation : Experience of the Cardiothoracic Surgical Trials Network. In: Journal of Thoracic and Cardiovascular Surgery. 2011 ; Vol. 142, No. 2.
    @article{e477461a7ffd4019889c2b6ae8b26368,
    title = "Designing comparative effectiveness trials of surgical ablation for atrial fibrillation: Experience of the Cardiothoracic Surgical Trials Network",
    abstract = "Objective: Since the introduction of the cut-and-sew Cox maze procedure for atrial fibrillation, there has been substantial innovation in techniques for ablation. Use of alternative energy sources for ablation simplified the procedure and has resulted in dramatic increase in the number of patients with atrial fibrillation treated by surgical ablation. Despite its increasingly widespread adoption, there is lack of rigorous clinical evidence to establish this procedure as an effective clinical therapy. Methods: This article describes a comparative effectiveness randomized trial, supported by the Cardiothoracic Surgical Clinical Trials Network, of surgical ablation with left atrial appendage closure versus left atrial appendage closure alone in patients with persistent and long-standing persistent atrial fibrillation undergoing mitral valve surgery. Nested within this trial is a further randomized comparison of 2 different lesions sets: pulmonary vein isolation and the full maze lesion set. Results: This article addresses trial design challenges, including how best to characterize the target population, operationalize freedom from atrial fibrillation as a primary end point, account for the impact of antiarrhythmic drugs, and measure and analyze secondary end points, such as postoperative atrial fibrillation load. Conclusions: This article concludes by discussing how insights that emerge from this trial may affect surgical practice and guide future research in this area.",
    author = "Gillinov, {A. Marc} and Michael Argenziano and Blackstone, {Eugene H.} and Alexander Iribarne and Derose, {Joseph J.} and Gorav Ailawadi and Russo, {Mark J.} and Ascheim, {Deborah D.} and Parides, {Michael K.} and Evelio Rodriguez and Denis Bouchard and Taddei-Peters, {Wendy C.} and Geller, {Nancy L.} and Acker, {Michael A.} and Gelijns, {Annetine C.}",
    year = "2011",
    month = "1",
    day = "1",
    doi = "10.1016/j.jtcvs.2011.04.010",
    language = "English (US)",
    volume = "142",
    journal = "Journal of Thoracic and Cardiovascular Surgery",
    issn = "0022-5223",
    publisher = "Mosby Inc.",
    number = "2",

    }

    TY - JOUR

    T1 - Designing comparative effectiveness trials of surgical ablation for atrial fibrillation

    T2 - Experience of the Cardiothoracic Surgical Trials Network

    AU - Gillinov, A. Marc

    AU - Argenziano, Michael

    AU - Blackstone, Eugene H.

    AU - Iribarne, Alexander

    AU - Derose, Joseph J.

    AU - Ailawadi, Gorav

    AU - Russo, Mark J.

    AU - Ascheim, Deborah D.

    AU - Parides, Michael K.

    AU - Rodriguez, Evelio

    AU - Bouchard, Denis

    AU - Taddei-Peters, Wendy C.

    AU - Geller, Nancy L.

    AU - Acker, Michael A.

    AU - Gelijns, Annetine C.

    PY - 2011/1/1

    Y1 - 2011/1/1

    N2 - Objective: Since the introduction of the cut-and-sew Cox maze procedure for atrial fibrillation, there has been substantial innovation in techniques for ablation. Use of alternative energy sources for ablation simplified the procedure and has resulted in dramatic increase in the number of patients with atrial fibrillation treated by surgical ablation. Despite its increasingly widespread adoption, there is lack of rigorous clinical evidence to establish this procedure as an effective clinical therapy. Methods: This article describes a comparative effectiveness randomized trial, supported by the Cardiothoracic Surgical Clinical Trials Network, of surgical ablation with left atrial appendage closure versus left atrial appendage closure alone in patients with persistent and long-standing persistent atrial fibrillation undergoing mitral valve surgery. Nested within this trial is a further randomized comparison of 2 different lesions sets: pulmonary vein isolation and the full maze lesion set. Results: This article addresses trial design challenges, including how best to characterize the target population, operationalize freedom from atrial fibrillation as a primary end point, account for the impact of antiarrhythmic drugs, and measure and analyze secondary end points, such as postoperative atrial fibrillation load. Conclusions: This article concludes by discussing how insights that emerge from this trial may affect surgical practice and guide future research in this area.

    AB - Objective: Since the introduction of the cut-and-sew Cox maze procedure for atrial fibrillation, there has been substantial innovation in techniques for ablation. Use of alternative energy sources for ablation simplified the procedure and has resulted in dramatic increase in the number of patients with atrial fibrillation treated by surgical ablation. Despite its increasingly widespread adoption, there is lack of rigorous clinical evidence to establish this procedure as an effective clinical therapy. Methods: This article describes a comparative effectiveness randomized trial, supported by the Cardiothoracic Surgical Clinical Trials Network, of surgical ablation with left atrial appendage closure versus left atrial appendage closure alone in patients with persistent and long-standing persistent atrial fibrillation undergoing mitral valve surgery. Nested within this trial is a further randomized comparison of 2 different lesions sets: pulmonary vein isolation and the full maze lesion set. Results: This article addresses trial design challenges, including how best to characterize the target population, operationalize freedom from atrial fibrillation as a primary end point, account for the impact of antiarrhythmic drugs, and measure and analyze secondary end points, such as postoperative atrial fibrillation load. Conclusions: This article concludes by discussing how insights that emerge from this trial may affect surgical practice and guide future research in this area.

    UR - http://www.scopus.com/inward/record.url?scp=79960407748&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=79960407748&partnerID=8YFLogxK

    U2 - 10.1016/j.jtcvs.2011.04.010

    DO - 10.1016/j.jtcvs.2011.04.010

    M3 - Article

    VL - 142

    JO - Journal of Thoracic and Cardiovascular Surgery

    JF - Journal of Thoracic and Cardiovascular Surgery

    SN - 0022-5223

    IS - 2

    ER -